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Abstract 
Purpose: To prepare and evaluate floating microspheres of curcumin for prolonged gastric residence 
and to study their effect on alloxan-induced diabetic rats.  
Methods: Floating microsphere were prepared by emulsion-solvent diffusion method, using 
hydroxylpropyl methylcellulose, chitosan and Eudragit S 100 polymer in varying proportions. 
Ethanol/dichloromethane blend was used as solvent in a ratio of 1:1. The floating microspheres were 
evaluated for flow properties, particle size, incorporation efficiency, as well as in-vitro floatability and 
drug release. The anti-diabetic activity of the floating microspheres of batch FM4 was performed on 
alloxaninduced diabetic rats.  
Result: The floating microspheres had particle size, buoyancy, drug entrapment efficiency and yield in 
the ranges of 255.32 - 365.65 μm, 75.58 - 89.59, 72.6 - 83.5, and 60.46 - 80.02 %, respectively. 
Maximum drug release after 24 h was 82.62 % for formulation FM4 and 73.879, 58.613 and 46.106 % 
for formulations FM1, FM2, and FM3 respectively. In-vivo data obtained over a 120-h period indicate 
that curcumin floating microspheres from batch FM4 showed the better glycemic control than control 
and a commercial brand of the drug.  
Conclusion: The developed floating curcumin delivery system seems economical and effective in 
diabetes management in rats, and enhances the bioavailability of the drug. 
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Glucose is necessary for health because it's an 
important source of energy for the cells that 
make muscles and tissues. When the blood 
glucose increases for example, after eating food 
material, insulin is released from the pancreas to 
normalize the glucose level [1]. Diabetes mellitus 
is a condition in which a person has a high blood 
sugar level, either because the body doesn’t 
produce enough insulin, or because body cells 
don’t properly respond to the insulin that is 
produced. If the body cells do not absorb 
glucose, the glucose accumulates in the blood, 
leading to vascular, neuron, and other 
complications. 
 
Diabetes mellitus is the commonest endocrine 
disorder that affects more than  171 million 
people worldwide and according to a recent 
study, this population may be increased 366 
million by 2030 [2]. 
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Natural products have received considerable 
attention for the management of diabetes and its 
complications which have reached epidemic 
proportion worldwide. The spice turmeric, which 
is derived from the root of the plant Curcuma 
longa, has been described as a treatment for 
diabetes in Ayurvedic and traditional Chinese 
traditional medicine for thousands of years [3]. 
 
Curcumin, a powerful antioxidant, is a 
component of turmeric found in the Curcuma 
longa plant and has been used for centuries in 
treating inflammatory ailments. Its anti-
inflammatory properties have been attributed to 
the main components of turmeric, the 
curcuminoids including Curcumin. Curcumin is a 
potent scavenger of reactive oxygen and 
nitrogen species such as hydroxyl radicals and 
nitrogen dioxide radicals [4]. The possible 
mechanisms of the effect of curcumin on 
glycemia in diabetes models may be explained 
as follows. First, curcumin could attenuate tumor 
necrosis factor- (TNF-α) levels and plasma free 
fatty acids. It also inhibits nuclear factor-kappa β 
(NF- β) activation and protein carbonyl [5] lipid 
peroxidation. Furthermore curcumin is involved in 
activating of enzymes in liver, which are 
associated with glycolysis, gluconeogenic, and 
lipid metabolic process [6]. 
 
Floating microspheres are gastroretentive drug 
delivery systems based on a non-effervescent 
approach. These microspheres are 
characteristically free-flowing powders having a 
size < 199 μm and remain buoyant over gastric 
contents for a prolonged period. As the system 
floats over gastric contents, the drug is released 
slowly at the desired rate, resulting in increased 
gastric retention with reduced fluctuations in 
plasma drug concentration [7]. The objective of 
present study was to develop a floating drug 
delivery system of Curcumin and to study their 
therapeutic effectiveness on alloxan induced 




Curcumin was a gift from Krish Enteprizes, 
Mumbai, India. HPMC and Eudragit S 100 were 
received as a gift samples from Glukem 
Pharmaceuticals (P) Ltd, India. All other 
chemicals used were of analytical grade. 
 
Preparation of floating microspheres  
 
The floating microspheres were prepared by 
emulsion solvent diffusion method [8]. The drug 
and polymer ratio used are shown in Table 1. 
The materials were weighed and added to a 
mixture of dichloromethane and ethanol. The 
slurry was introduced into 250 ml beaker 
containing tween 80 while being stirred at 750 
rpm by mechanical stirrer (Eltek Motor, Mumbai) 
for 1 h at room temperature. The floating 
microspheres were collected by decantation 
while the non-floating microspheres were 
discarded along with polymer residues and 
washed thrice with n-hexane. The collected 
microspheres were dried overnight in an oven at 
40 ± 2 oC and stored in a desiccators containing 
calcium chloride as a desiccant. 
 
Table 1: Composition of formulations 
 
Ingredient FM1 FM2 FM3 FM4 
Curcumin (mg) 100 100 100 100 
Eudragit S100 (mg) 150 250 500 - 
Chitosan (mg) - - 150 250 
HPMC (mg) - - 150 200 
Dichloromethane:ethanol 
1:1 (ml) 
5:5 5:5 5:5 5:5 
Tween 80 (ml) 2 2 2 2 
 
Evaluation of floating microsphere 
 
Particle size analysis  
 
The particle size was measured by microscopic 
technique. In this method suspension of floating 
microspheres was prepared using castor oil. A 
drop of suspension was mounted on a slide and 
observed under optical microscope (VN-7, 
Cosmo Lab, India) about 600 particles were 
measured with the help of the eye piece 
micrometer.  All the microspheres in a field were 
counted [9]. 
 
Measurement of bulk density 
 
In this method, floating microspheres were 
transferred to a measuring cylinder and tapped 
manually till a constant volume was obtained. 
This volume is bulk volume and it included the 
true volume of the powder and the void space 
among the microspheres. Bulk density was 
computed as the ratio of the mass of the 
microsphere to the bulk volume [8].  
 
Bulk Density = (Mass of microspheres)/(Bulk 
Volume)Measurement of tapped density 
 
In this method floating microspheres were 
transferred to a measuring cylinder and tapped 
for 100 times. After tapping volume of 
microspheres was visually examined. The ratio of 
mass of microspheres to volume of microspheres 
after tapping gave the tapped density of the 
floating microspheres [10].  
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Tapped Density = (Mass of 
microspheres)/(Volume of microspheres after 
tapping) 
 
Measurement of Carr’s (compressibility) 
index 
 
This parameter was calculated from bulk density 
(the ratio of weighed quantity of microspheres to 
its volume), DP, and tapped density as in Eq 1. 
 
Compressibility index = (DT-DP)/DX × 100… (1) 
 
Measurement of Hausners ratio  
 
Hausners ratio of microspheres was determined 
as the ratio of tapped density to bulk.  
 
Hausners ration = (Bulk density)/(Tapped 
density) 
 
Values < 1.25 indicate good flow (= 20 % Carr), 
while values > 1.25 indicate poor flow [8]. 
 
Evaluation of angle of repose  
 
Angle of repose (θ) of the microspheres, which 
measures the resistance to particle flow, was 
determined by a fixed funnel method4. The 
height (h) and radius (r) of the powder cone was 
measured and angle of repose was calculated 
using Eq 2 [10]. 
 
θ = tan-1 h/r…………….……… (2) 
 
Measurement of drug entrapment efficiency  
 
Microspheres equivalent to 50 mg of the drug 
were taken for evaluation. The amount of drug 
entrapped was estimated by crushing the 
microspheres and extracting with aliquots of 0.1 
N HCl repeatedly. The extract was transferred to 
a 100 ml volumetric flask and the volume was 
made up using 0.1 N HCl. The solution was 
filtered and the absorbance was measured at 
254 nm by UV spectrophotometer (Shimadzu) 
against appropriate blank [10]. The amount of 
drug entrapped in the microspheres was 
calculated as the ratio of the actual amount of 
drug found in the microsphere to the theoretical 
drug load, expressed as a percentage.    
 
Determination of microsphere yield  
 
The prepared microspheres were weighed. The 
measured weight was divided by the total 
amount of all non-volatile components which 
were used for the preparation of the 
microspheres, and then expressed as a 
percentage. 
 
Assessment in-vitro buoyancy  
 
Microspheres (300 mg) were spread over the 
surface of a USP XXIV dissolution apparatus 
type II (Electro Labs, Mumbai) filled with 900 ml 
of 0.1 N hydrochloric acid containing 0.02 % 
tween 80. The medium was agitated with a 
paddle rotating at 100 rpm. The floating and the 
settled portions of microspheres were recovered 
separately. The microspheres were dried and 
weighed. Buoyancy percentage was calculated 
as the ratio of the mass of the microspheres that 
remained floating to the total mass of the 
microspheres, expressed as a percentage [11]. 
   
In-vitro drug release studies  
 
A USP basket apparatus was used to study in-
vitro drug release from microspheres. In the 
present study drug release was studied using a 
modified USP XXIV dissolution apparatus type I 
((Electro Labs, Mumbai)) at 100 rpm in distilled 
water and 0.1 mol L-1 HCL (pH 1.2) as 
dissolution fluids (900 ml) maintained at 37 ± 1 
oC. Aliquots were withdrawn at periodical 
intervals and analyzed spectrophotometrically at 
254 nm. The volume was replenished with the 
same amount of fresh medium to maintain the 
sink condition. All experiments were performed in 
triplicate [12]. 
 
Assessment of hypoglycaemic activity 
 
The approval of the Institutional Animal Ethics 
Committee was obtained before starting the 
study. The study was carried out as per the 
guidelines compiled by the Committee for the 
Purpose of Control and Supervision of 
Experiments on Animal (CPCSEA), Ministry of 
Culture, Government of India and all the study 
protocols were approved by the local institutional 
Animal Ethics Committee PSIT, Kanpur, India 
(R.N.-1237/AC/CPCSEA). Also an international 
protocol for conducting experiments on animals 
were followed [13]. Healthy wistar rats of either 
sex having weight 150 - 200 g were selected for 
this activity. They were housed in standard 
condition of temperature (25 ± 2 oC) with 12 h 
light per day cycle. Before induction of diabetes 
weigh and normal glucose levels of rats were 
determined and recorded as Day 0.  The 
acclimatized animals were fasted for 24 h with 
water ad libitum and injected intraperitoneally 
freshly prepared alloxan monohydrate in normal 
at a dose of 150 mg/kg body weight [14]. All 
animals were returned to their cages and given 
free access to food and water. Blood glucose 
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levels were monitored by using a Glucometer 
(Pulsatum Health Care Pvt. Ltd., India) after 72 h 
of injection and recorded as 1st day. Only rats 
with fasting blood glucose level greater than 250 
mg/ml were considered diabetic and included in 
this study. Diabetic rats were randomly assigned 
to three groups, each group contains six animals.  
 
The animals were grouped as follows: 
 
a) Diabetic control: normal saline solution 
 
b) Floating microspheres formulation of Group 
FM4: (200 mg/kg) 
 
d) Standard group: Glibenclamide: (10 mg/kg 
body weight orally by dissolving in normal saline 
solution). 
 
Glucometer (Pulsatum Health Care Pvt Ltd, 
India) was used to monitor blood glucose levels 
of the rats. Blood samples were obtained from 
the cut tail tip of the conscious rat and glucose 
test strip soaked with blood and then inserted to 
be read by the glucometer. Blood glucose levels 
were examined after 2, 12, 24, 72, 120 h of orally 




To ascertain drug release mechanism and 
release rate, the release data were model fitted 
using PCP Disso V3.0 dissolution software. 
Experimental results were expressed as mean ± 
SD. Student’s t-test and one-way analysis of 
variance (ANOVA) were applied to check 
significant differences in drug release from 
different formulations. Differences were 





Properties of floating microspheres 
 
The properties of the microspheres are shown in 
Table 2, Table 3, Table 3 and Fig 1. Mean 
particle size significantly increased with 
increasing polymer concentration this was due to 
high viscosity of polymer concentration require 
high energy for breaking of droplets. The 
microspheres were more difficult to disperse; 
these results in larger size of microspheres. The 
drug entrapment efficiency of different batches of 
floating microspheres was found in range of 
73.56 - 80.02. A large proportion of the 
microspheres remained floating after 12 h. 
Floatation might have been influenced by the low 
bulk and tapped densities of the microspheres. 
Buoyancy for all the batches was above 75 %, 
which was studied for 12 h. Mean buoyancy 
ranged from 75.58 to 89.59 %. Highest buoyancy 
was obtained with formulation FM4. In general 
with increase in the amount of polymer 
(chitosan), there was an increase in the 
buoyancy percentage. 
 
The release profiles of curcumin varied with the 
different formulations. Curcumin release from 
these microspheres was slow, extended and 
dependent on the type of polymer used. In-vitro 
release study shows maximum release for 




Table 2: Characteristics of floating microspheres 
 
Parameter FM1 FM2 FM3 FM4 
Particle size (µ m) 255.32±0.135 263.87±0.253 321.52±0.332 365.65±0.158 
Bulk density (g/cm3) 0.154±0.014 0.160±0.024 0.163±0.015 0.170±0.039 
Tapped density (g/cm3) 0.172±0.153 0.212±0.230 0.209±0.036 0.218±0.126 
Hausner,s ratio 1.118±0.028 1.193±0.005 1.139±0.007 1.146±0.142 
Carr’s index 17.14±0.142 20.53±0.234 19.43±0.104 15.0±0.208 
Angle of repose 17.510±0.016 18.510±0.021 20.870±0.113 22.080 ±0.327 
Buoyancy (%) 75.58±0.134 87.26±0.316 84.61±0.138 89.59±0.226 
Yield (%) 60.46±0.138 61.12±0.118 73.56±0.074 80.02±0.062 
Drug entrapment 
Efficiency (%) 
73.56±0.024 79.25±0.047 81.21±0.072 82.45±0.035 
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Figure 1: Drug release profiles of curcumin from floating microspheres (      ◊= FM1; □ FM2; Δ= FM3; O = 
FM4) 
 




 Zero order  Higuchi model  Korsemeyer-Peppas model 
 
R K R K Slope (n) R K 
FM1 0.8541 1.1454 0.9627 10.0362 0.6841 0.9641 5.1338 
FM2 0.8224 1.2632 0.9543 9.5253 0.6495 0.9678 5.0788 
FM3 0.9052 1.1566 0.9848 10.1451 0.6581 0.9732 4.0586 
FM4 0.9121 1.2882 0.9857 10.1244 0.6746 0.9664 6.1685 
 





0 2 12 24 72 120 
Diabetic Control 362.42 364.49 372.61 380.82 390.83 400.28 
Floating microspheres, batch FM4 350.27 338.62 324.71 312.42 290.38 270.62 
Diabetic + Glibenclamide 348.42 322.53 306.41 284.31 268.83 260.34 




Drug absorption in the gastrointestinal tract is a 
highly variable process. Floating microspheres 
are promises to be a potential approach for 
gastric retention to enhance the bioavailability. 
 
Floating microspheres as gastroretentive dosage 
forms precisely control the release rate of target 
drug to a specific site and facilitate an enormous 
impact on health care. After oral administration, 
these are retained in the stomach and release 
the drug there in a controlled and prolonged 
manner to allow the drug to be supplied 
continuously to its absorption sites in the upper 
gastrointestinal tract.  
 
The present study is an attempt to formulate 
curcumin floating microspheres formulations with 
a view of improving its oral bioavailability and 
giving a prolonged release of drug, and also to 
study their effect on alloxan-induced diabetic 
rats. 
 
Drug entrapment efficiency increased with 
increasing polymer concentration in floating 
microspheres. The high entrapment efficiency of 
curcumin is believed to be due to its poor 
aqueous solubility in disperse phase. The 
percentage entrapment efficiency increased with 
increase in polymer concentration because 
higher viscosity of chitosan solution reduces the 
diffusion of the drug in the surroundings which 
does not allow entrapped particle to escape 
easily.  
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Eudragit S 100 is insoluble in acidic medium and 
also exhibits low permeability. It is an anionic 
copolymer of methacrylic acid and methyl 
methacrylate containing free carboxylic and ester 
groups [15]. The initial drug release significantly 
increased with an increase in the ratio of 
drug/polymer. An initial high release was 
observed due to the dissolution of surface 
adhered drug, whereas the latter release was 
due to the diffusion process, which is much 
slower when, compared to the initial release. The 
regression coefficient values for all these models 
are shown in Table 4. The models selected were 
zero order, Higuchi, Korsemeyer-Peppas. The 
zero order plots showed the zero order release 
characteristics of the formulation, which was 
confirmed by the correlation value which found to 
be nearer to one. Correlation value of Higuchi’s 
plot revealed that the mechanism of drug release 
is diffusion. The in vitro kinetic data subjected to 
log time log drug release transformation n plot 
(Peppas’ model) revealed the fact that the drug 
release follows a super case II transport 
diffusion. In all the cases the best fit model was 
found to be Peppas with ‘n’ value between 
0.6495 and 0.6841, suggesting a non-Fickian 
(anomalous) release mechanism for the drug, 
i.e., erosion followed by diffusion controlled. 
Alloxan administration resulted in significant 
elevation of glucose level and reduction in body 
weight. The in-vivo study of curcumin floating 
microspheres (FM4) showed optimal glycemic 
control is best when compared with control and 
Marketed product.  
 
Alloxan causes diabetes through its ability to 
destroy the insulin-producing beta cells of the 
pancreas. In vitro studies have shown that 
alloxan is selectively toxic to pancreatic beta 
cells, leading to the induction of cell necrosis. 
The cytotoxic action of alloxan is mediated by 
reactive oxygen species, with a simultaneous 
massive increase in cytosolic calcium 
concentration, leading to a rapid destruction of 
beta cells [16]. In light of the results, study 
indicates that floating microspheres of curcumin 




The findings suggest that gastro retentive floating 
microspheres have the potentials to be 
developed as an efficient delivery system for 
enhanced bioavailability and controlled delivery 
of curcumin for diabetes therapy as it contains 
various complex chemical substance of different 
composition in the form of secondary plant 
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